UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000001676
Receipt No. R000002024
Scientific Title Multicenter cohort study to investigate the risk of metachronous multiple cancers and assess the period required for their development after EMR, using Lugol-voiding pattern as a biomarker in patients with esophageal squamous cell carcinoma
Date of disclosure of the study information 2009/01/31
Last modified on 2021/10/13 21:35:39

No. Disposal Last modified on Item of update
1 Insert 2009/01/31 14:54:49
2 Update 2010/01/03 15:43:53 Recruitment status
Last follow-up date
3 Update 2011/04/19 13:56:14 Recruitment status
Last follow-up date
4 Update 2021/10/13 21:03:57 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Division name
Division name
Zip code
TEL
Email

Last name of contact person

Last name of contact person
Zip code
TEL
Email
Organization
Division name
Address
Address
Name of primary sponsor
Institute
Institute
Organization
Organization
Organization
Category of Funding Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
Organization
Organization
Address
Address
Tel
Email
5 Update 2021/10/13 21:15:53 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
6 Update 2021/10/13 21:20:28 Date of IRB
Last follow-up date
7 Update 2021/10/13 21:23:38 Name of primary sponsor
Institute
Institute
Organization
Organization
Organization
Category of Funding Organization
Nationality of Funding Organization
Nationality of Funding Organization
8 Update 2021/10/13 21:35:39 Publication of results
Number of participants that the trial has enrolled


Contact us.